Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

NCCAM

This article was originally published in The Tan Sheet

Executive Summary

NIH center's program advisory panel holding its initial meeting July 8-9 at the Bethesda Marriott, 5151 Pooks Hill Road, Bethesda, Md. The agenda includes comments from NCCAM Acting Director William Harlan, MD, and other NIH staffers, as well as scientific presentations on alternative cancer treatments. The meeting will be open to the public from 8:30 a.m. to 12:15 p.m. on July 8 and from 8:30 a.m. to 1:30 p.m. July 9; people wishing to make public comments should contact Richard Nahin at (301)-594-2013. The advisory panel originally met Nov. 16 but subsequently had to revise its charter ("The Tan Sheet" March 8, p. 7)

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS089991

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel